-
SCHOTT increases global sales and earnings; India plant vital for fighting Coronavirus worldwide
expresspharma
February 03, 2021
The international specialty glass group SCHOTT is continuing its positive development and is setting the course for a new phase of growth with its ongoing investment programme.
-
Business optimism improves in December amid COVID-19 vaccine rollout: Poll
pharmaceutical-technology
January 11, 2021
Emerging economies are projected to benefit the most from vaccine rollout, which is expected to differ between countries. While some countries may be able to effectively administrate vaccines, others may fall short of inoculating roughly 30% of their popu
-
World awaits India’s vaccines, watching how it handles globe’s biggest vaccination drive: PM Modi
expresspharma
January 11, 2021
He said the country is among the nations with the lowest fatality rate and the highest recovery rate.
-
We might need to redefine our approach to drug discovery and approval to be prepared for the future
expresspharma
January 08, 2021
Hitesh Windlass, MD, Windlas Biotech gives an overview of the changes bought by COVID-19 pandemic in the pharma industry, his organisation’s plans for future growth and more, in an interview with Lakshmpriya Nair.
-
Universiti Teknologi Malaysia Community responded to COVID-19 threats through R&D
prnasia
December 29, 2020
Researchers from Universiti Teknologi Malaysia (UTM) have swung into action to respond to the threat posed by COVID-19 pandemic.
-
AYUSH industry grew by 44 per cent in nine months of COVID-19 pandemic: AYUSH Secretary
expresspharma
December 21, 2020
Speaking at an event organised by Assocham, he appealed to the industry to come forward and help in developing and propagating AYUSH drugs and medicines in the future.
-
Future Uncertainty Hangs Heavy in Cigna COVID-19 Study
prnasia
December 17, 2020
Cigna's International Markets business today published the fourth edition of its COVID-19 Global Impact Study, which reveals that people are increasingly worried about the long-term impact of the COVID-19 pandemic.
-
Pandemic has made little positive impact on public's view of pharma
pharmatimes
December 16, 2020
Contrary to popular belief COVID-19 has actually had little positive impact on perceptions of pharmaceutical companies, finds a new report launched by Takeda UK.
-
New research reveals impact of childhood type 1 diabetes on mental health
pharmatimes
December 16, 2020
New research surveys released by medical device company Abbott have revealed the impact of childhood type 1 diabetes (T1D) on the emotional and mental health of children and their families in the UK.
-
Pharmacovigilance during a pandemic
expresspharma
December 10, 2020
As coronavirus has become the new reality for every health worker and life science company to fight in the front, it is time to relook the approach being taken by the industry towards pharmacovigilance.